Halozyme Therapeutics Current Ratio 2010-2024 | HALO

Halozyme Therapeutics current ratio for the quarter ending June 30, 2024 was 7.43.

  • Halozyme Therapeutics average current ratio for 2023 was 6.9, a 19.17% increase from 2022.
  • Halozyme Therapeutics average current ratio for 2022 was 5.79, a 32.83% increase from 2021.
  • Halozyme Therapeutics average current ratio for 2021 was 8.62, a 31.26% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.

Halozyme Therapeutics Current Ratio 2010-2024 | HALO

  • Halozyme Therapeutics average current ratio for 2023 was 6.9, a 19.17% increase from 2022.
  • Halozyme Therapeutics average current ratio for 2022 was 5.79, a 32.83% increase from 2021.
  • Halozyme Therapeutics average current ratio for 2021 was 8.62, a 31.26% decline from 2020.

Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.